Cigna Group (NYSE: CI) insider to sell 2,677 common shares
Rhea-AI Filing Summary
Cigna Group (CI) insider Nicole S. Jones filed a Rule 144 notice covering planned sales of common stock. The filing lists a planned stock option exercise and potential sale of 2,677 shares of Cigna common stock on 08/18/2025, for cash, through Fidelity Brokerage Services LLC. It also reports that during the past three months, Jones sold 19,436 shares of Cigna common stock for aggregate proceeds of $5,369,583.72.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 2,677 shares
Past 3-month shares sold: 19,436 shares
Past 3-month sale proceeds: $5,369,583.72
+2 more
5 metrics
Planned shares to be sold
2,677 shares
Common stock tied to a stock option exercise dated 08/18/2025
Past 3-month shares sold
19,436 shares
Cigna Group common stock sold by Nicole S. Jones during the past 3 months
Past 3-month sale proceeds
$5,369,583.72
Aggregate proceeds from 19,436 Cigna Group shares sold on 08/04/2026
Planned option exercise date
08/18/2025
Date of stock option exercise related to 2,677 shares
Issuer phone number
8602266000
Cigna Group issuer contact phone
Key Terms
Rule 144, stock option exercise, attorney-in-fact
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
stock option exercise financial
"Common | 08/18/2025 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as attorney-in-fact for Nicole S. Jones."
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
What does the Form 144 filing by Nicole S. Jones mean for Cigna Group (CI)?
The filing discloses that Nicole S. Jones plans to sell 2,677 shares of Cigna Group common stock after a stock option exercise on 08/18/2025, as required under Rule 144 for certain insider and affiliate sales.
What Cigna Group (CI) insider sales has Nicole S. Jones made in the past 3 months?
Over the past three months, Nicole S. Jones has sold 19,436 shares of Cigna Group common stock, with aggregate sale proceeds of $5,369,583.72. These prior sales are reported as part of the Form 144 historical disclosure requirement.
On what date is the planned Cigna Group (CI) stock option exercise and sale for Nicole S. Jones?
The filing identifies 08/18/2025 as the date of the planned stock option exercise related to 2,677 shares of Cigna common stock, which are expected to be sold for cash under Rule 144 procedures.
What type of Cigna Group (CI) security is covered by this Form 144 filing?
The filing covers common stock of Cigna Group. It details a planned stock option exercise and subsequent cash sale of 2,677 common shares on 08/18/2025, plus past three-month sales information.
AI-generated analysis. How Rhea-AI works. Not financial advice.